Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
Chih‐Hao Lee, Ronald M. Evans · Trends in Endocrinology and Metabolism · 2002
Cited by 85 works. doi:10.1016/s1043-2760(02)00668-9
Authors
References
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
- Atherosclerosis
- PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
- Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
- Atherosclerosis
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ